US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 34.040
  • -0.590-1.70%
Trading Dec 4 14:14 ET
4.23BMarket Cap-16768P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q3
Stock NameRevenueRatio
SYFOVRE151.96M77.20%
EMPAVELI24.61M12.50%
Licensing and other revenue20.26M10.29%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States396.59M100.00%
Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Gene Editing
Gene Editing
Intraday+0.52%